INS and Alzheimer disease: Early reports examining post‐mortem AD brains, describe impaired insulin binding (Rivera et al., 2005), reduced insulin receptor content (Steen et al., 2005), and increased inhibitory phosphorylation of various serine sites of IRS‐1 (Moloney et al., 2010).